Checkpoint Inhibitors in Malignant Pleural Mesothelioma
0 צפיות
• 07/02/23
0
0
לְשַׁבֵּץ
administrator
מנויים
Mark Socinski, MD; Mary Jo Fidler, MD; Roy Herbst, MD, PhD; Geoffrey Oxnard, MD; and Naiyer Rizvi, MD discuss the potential for checkpoint inhibitors, such as pembrolizumab, for malignant mesothelioma. Also discussed is the importance of trials that can be done in the community setting.
להראות יותר
תגובות בפייסבוק
SORT BY-
תגובות ראשיות
-
תגובות אחרונות